Skip to content

Bc Thrombin Reagent

by Behring Diagnostics, Inc. 510(k)

Active United States

510(k) K970645

Regulatory status

as of 28 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK970645 Date19 May 1997ClearedStatusActive

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Recalls

2 recalls · FDA

    • Terminated Z-0827-2018 FDA Class II initiated 17 Oct 2017

    The BC Thrombin Reagent kit lot 46751 (contains Thrombin Reagent lot 517468) and kit lot 47184 (contains Thrombin Reagent lot 517469) produce unexpected prolonged Thrombin Time (TT) results for expected normal samples, and may recover above the upper limit of normal (< 21 sec.) as stated within the IFU (Instruction For Use).

    • Terminated Z-0007-05 FDA Unclassified (pre-2012) initiated 21 Jul 2004

    The product does not demonstrate the expected prolonged thrombin times for specimens obtained from patients recieving heparin

Specification

510(k)

510(k) Number
FDA Product Code
GJA
Device Class
Class II
Regulation
21 CFR Part 864.7875
Advisory Committee
Hematology
FDA Decision
SESE Substantially Equivalent

Other devices from Behring Diagnostics, Inc.

See all devices from Behring Diagnostics, Inc. →